Cav3.2
316 literature references associated to Cav3.2
1
Berecki G
et al.
Mechanism of direct Cav2.2 channel block by the κ-opioid receptor agonist U50488H.
Neuropharmacology,
2016
May
28
, 109 (49-58).
2
Long D
et al.
Identification of genetic variants associated with susceptibility to West Nile virus neuroinvasive disease.
Genes Immun.,
2016
May
12
, ().
3
Voisin T
et al.
Genetic alteration of the metal/redox modulation of Cav3.2 T-type calcium channel reveals its role on neuronal excitability.
J. Physiol. (Lond.),
2016
Mar
2
, ().
4
Yang W
et al.
Cannabinoid receptor agonists modulate calcium channels in rat retinal müller cells.
Neuroscience,
2016
Jan
28
, 313 (213-24).
5
Hurtado R
et al.
Hyperpolarization-activated cation and T-type calcium ion channel expression in porcine and human renal pacemaker tissues.
J. Anat.,
2016
Jan
25
, ().
6
Elíes J
et al.
Regulation of the T-type Ca(2+) channel Cav3.2 by hydrogen sulfide: Emerging controversies concerning the role of H2 S in nociception.
J. Physiol. (Lond.),
2016
Jan
25
, ().
7
Makarenko VV
et al.
CaV3.2 T-type Ca2+ channels mediate the augmented calcium influx in carotid body glomus cells by chronic intermittent hypoxia.
J. Neurophysiol.,
2016
Jan
1
, 115 (345-54).
8
Sakkaki S
et al.
A role of T-type calcium channels in tonic-clonic seizures as revealed by the anticonvulsant properties of the blocker TTA-A2.
Neuropharmacology,
2015
Oct
9
, ().
9
Butler MG
et al.
Currently recognized genes for schizophrenia: High-resolution chromosome ideogram representation.
Am. J. Med. Genet. B Neuropsychiatr. Genet.,
2015
Oct
13
, ().
10
Fukami K
et al.
Functional upregulation of the H2S/Cav3.2 channel pathway accelerates secretory function in neuroendocrine-differentiated human prostate cancer cells.
Biochem. Pharmacol.,
2015
Oct
1
, 97 (300-9).
11
Siapich SA
et al.
Low concentrations of ethanol but not of dimethyl sulfoxide (DMSO) impair reciprocal retinal signal transduction.
Graefes Arch. Clin. Exp. Ophthalmol.,
2015
Oct
, 253 (1713-9).
12
Park SJ
et al.
Differential zinc permeation and blockade of L-type Ca2+ channel isoforms Cav1.2 and Cav1.3.
Biochim. Biophys. Acta,
2015
Oct
, 1848 (2092-100).
13
Blesneac I
et al.
Phosphorylation of the Cav3.2 T-type calcium channel directly regulates its gating properties.
Proc. Natl. Acad. Sci. U.S.A.,
2015
Nov
3
, 112 (13705-10).
14
Harraz OF
et al.
CaV1.2/CaV3.x channels mediate divergent vasomotor responses in human cerebral arteries.
J. Gen. Physiol.,
2015
May
, 145 (405-18).
15
Felizola SJ
et al.
Pre-B Lymphocyte Protein 3 (VPREB3) Expression in the Adrenal Cortex: Precedent for non-Immunological Roles in Normal and Neoplastic Human Tissues.
Endocr. Pathol.,
2015
May
, 26 (119-28).
16
Curran J
et al.
Eps15 Homology Domain-containing Protein 3 Regulates Cardiac T-type Ca2+ Channel Targeting and Function in the Atria.
J. Biol. Chem.,
2015
Mar
30
, ().
17
Neumaier F
et al.
Voltage-gated calcium channels: Determinants of channel function and modulation by inorganic cations.
Prog. Neurobiol.,
2015
Mar
25
, ().
18
Zhang L
et al.
Lipopolysaccharides upregulate calcium concentration in mouse uterine smooth muscle cells through the T-type calcium channels.
Int. J. Mol. Med.,
2015
Mar
, 35 (784-90).
19
Monteil A
et al.
Inhibition of Cav3.2 T-type Calcium Channels by Its Intracellular I-II Loop.
J. Biol. Chem.,
2015
Jun
26
, 290 (16168-76).
20
Elíes J
et al.
H2S does not regulate proliferation via T-type Ca2+ channels.
Biochem. Biophys. Res. Commun.,
2015
Jun
12
, 461 (659-64).
21
Tompkins JD
et al.
Nickel suppresses the PACAP-induced increase in guinea pig cardiac neuron excitability.
Am. J. Physiol., Cell Physiol.,
2015
Jun
1
, 308 (C857-66).
22
Enyeart JJ
et al.
Adrenal fasciculata cells express T-type and rapidly and slowly activating L-type Ca2+ channels that regulate cortisol secretion.
Am. J. Physiol., Cell Physiol.,
2015
Jun
1
, 308 (C899-918).
23
Bladen C
et al.
1,4-Dihydropyridine derivatives with T-type calcium channel blocking activity attenuate inflammatory and neuropathic pain.
Pflugers Arch.,
2015
Jun
, 467 (1237-47).
24
Wang G
et al.
CaV3.2 calcium channels control NMDA receptor-mediated transmission: a new mechanism for absence epilepsy.
Genes Dev.,
2015
Jul
15
, 29 (1535-51).
25
Martinello K
et al.
Cholinergic afferent stimulation induces axonal function plasticity in adult hippocampal granule cells.
Neuron,
2015
Jan
21
, 85 (346-63).
26
Makarenko VV
et al.
CaV3.2 T-type Ca²⁺ channels in H₂S-mediated hypoxic response of the carotid body.
Am. J. Physiol., Cell Physiol.,
2015
Jan
15
, 308 (C146-54).
27
Francois A
et al.
The Low-Threshold Calcium Channel Cav3.2 Determines Low-Threshold Mechanoreceptor Function.
Cell Rep,
2015
Jan
14
, ().
28
Wang Q
et al.
[Effects of bisphenol A on voltage-dependent T-type calcium channels in mouse testis and epididymis, and the role of estrogen receptors].
Wei Sheng Yan Jiu,
2015
Jan
, 44 (23-7).
29
Cretoiu SM
et al.
Isolated human uterine telocytes: immunocytochemistry and electrophysiology of T-type calcium channels.
Histochem. Cell Biol.,
2015
Jan
, 143 (83-94).
30
Hamby AM
et al.
CaV3.2 KO mice have altered retinal waves but normal direction selectivity.
Vis. Neurosci.,
2015
Jan
, 32 (E003).
31
Bladen C
et al.
Characterization of novel cannabinoid based T-type calcium channel blockers with analgesic effects.
ACS Chem Neurosci,
2015
Feb
18
, 6 (277-87).
32
Liao P
et al.
Alternative splicing generates a novel truncated Cav1.2 channel in neonatal rat heart.
J. Biol. Chem.,
2015
Feb
18
, ().
33
Hansen PB
Functional importance of T-type voltage-gated calcium channels in the cardiovascular and renal system: news from the world of knockout mice.
Am. J. Physiol. Regul. Integr. Comp. Physiol.,
2015
Feb
15
, 308 (R227-37).
34
Weaver EM
et al.
Regulation of T-type calcium channel expression by sodium butyrate in prostate cancer cells.
Eur. J. Pharmacol.,
2015
Feb
15
, 749 (20-31).
35
Männikkö R
et al.
Pharmacological and electrophysiological characterisation of hERG activator AZSMO-23.
Br. J. Pharmacol.,
2015
Feb
12
, ().
36
Fukunaga K
[Cognitive Function and Calcium. Cognitive improvement through T type calcium channel stimulation].
Clin Calcium,
2015
Feb
, 25 (247-54).
37
Duckles H
et al.
Heme oxygenase-1 regulates cell proliferation via carbon monoxide-mediated inhibition of T-type Ca2+ channels.
Pflugers Arch.,
2015
Feb
, 467 (415-27).
38
Murakami-Nakayama M
et al.
Polaprezinc attenuates cyclophosphamide-induced cystitis and related bladder pain in mice.
J. Pharmacol. Sci.,
2015
Feb
, 127 (223-8).
39
Terada Y
et al.
Roles of Cav3.2 and TRPA1 channels targeted by hydrogen sulfide in pancreatic nociceptive processing in mice with or without acute pancreatitis.
J. Neurosci. Res.,
2015
Feb
, 93 (361-9).
40
Samour MS
et al.
Cav3.2-expressing low-threshold C fibres in human hairy skin contribute to cold allodynia--a non-TRPV1- and non-TRPM8-dependent phenomenon.
Pain,
2015
Aug
, 156 (1566-75).
41
Lv N
et al.
Association study between polymorphisms in the CACNA1A, CACNA1C, and CACNA1H genes and drug-resistant epilepsy in the Chinese Han population.
Seizure,
2015
Aug
, 30 (64-9).
42
Harraz OF
et al.
Genetic ablation of CaV3.2 channels enhances the arterial myogenic response by modulating the RyR-BKCa axis.
Arterioscler. Thromb. Vasc. Biol.,
2015
Aug
, 35 (1843-51).
43
Fukami K
et al.
Hydrogen sulfide and neuronal differentiation: focus on Ca2+ channels.
Nitric Oxide,
2015
Apr
30
, 46 (50-4).
44
Tomasova L
et al.
Effects of AP39, a novel triphenylphosphonium derivatised anethole dithiolethione hydrogen sulfide donor, on rat haemodynamic parameters and chloride and calcium Cav3 and RyR2 channels.
Nitric Oxide,
2015
Apr
30
, 46 (131-44).
45
Staehlke S
et al.
Intracellular calcium dynamics dependent on defined microtopographical features of titanium.
Biomaterials,
2015
Apr
, 46 (48-57).
46
Elíes J
et al.
Inhibition of T-type Ca(2+) Channels by Hydrogen Sulfide.
Adv. Exp. Med. Biol.,
2015
, 860 (353-60).
47
Tang J
et al.
Chronic hypoxia in pregnancy affected vascular tone of renal interlobar arteries in the offspring.
Sci Rep,
2015
, 5 (9723).
48
Chung NC
et al.
Behavior training reverses asymmetry in hippocampal transcriptome of the cav3.2 knockout mice.
PLoS ONE,
2015
, 10 (e0118832).
49
Shen FY
et al.
Alleviation of neuropathic pain by regulating T-type calcium channels in rat anterior cingulate cortex.
Mol Pain,
2015
, 11 (7).
50
Gadotti VM
et al.
Small organic molecule disruptors of Cav3.2 - USP5 interactions reverse inflammatory and neuropathic pain.
Mol Pain,
2015
, 11 (12).
51
Watanabe M
et al.
Expression and Regulation of Cav3.2 T-Type Calcium Channels during Inflammatory Hyperalgesia in Mouse Dorsal Root Ganglion Neurons.
PLoS ONE,
2015
, 10 (e0127572).
52
Duzhyy DE
et al.
Upregulation of T-type Ca2+ channels in long-term diabetes determines increased excitability of a specific type of capsaicin-insensitive DRG neurons.
Mol Pain,
2015
, 11 (29).
53
Nagi SS
et al.
The effects of preferential A- and C-fibre blocks and T-type calcium channel antagonist on detection of low-force monofilaments in healthy human participants.
BMC Neurosci,
2015
, 16 (52).
54
Saito Y
et al.
Enhancement of Spontaneous Activity by HCN4 Overexpression in Mouse Embryonic Stem Cell-Derived Cardiomyocytes - A Possible Biological Pacemaker.
PLoS ONE,
2015
, 10 (e0138193).
55
van Loo KM
et al.
Zinc regulates a key transcriptional pathway for epileptogenesis via metal-regulatory transcription factor 1.
Nat Commun,
2015
, 6 (8688).
56
Brun J
et al.
Smooth Muscle-Like Cells Generated from Human Mesenchymal Stromal Cells Display Marker Gene Expression and Electrophysiological Competence Comparable to Bladder Smooth Muscle Cells.
PLoS ONE,
2015
, 10 (e0145153).
57
Terada Y
et al.
H2S and Pain: A Novel Aspect for Processing of Somatic, Visceral and Neuropathic Pain Signals.
Handb Exp Pharmacol,
2015
, 230 (217-30).
58
Srinivasan PP
et al.
Inhibition of T-Type Voltage Sensitive Calcium Channel Reduces Load-Induced OA in Mice and Suppresses the Catabolic Effect of Bone Mechanical Stress on Chondrocytes.
PLoS ONE,
2015
, 10 (e0127290).
59
Scholl UI
et al.
Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism.
Elife,
2015
, 4 (e06315).
60
Garcia-Caballero A
et al.
The deubiquitinating enzyme USP5 modulates neuropathic and inflammatory pain by enhancing Cav3.2 channel activity.
Neuron,
2014
Sep
3
, 83 (1144-58).
61
Harraz OF
et al.
Ca(V)3.2 channels and the induction of negative feedback in cerebral arteries.
Circ. Res.,
2014
Sep
12
, 115 (650-61).
62
Chevalier M
et al.
T-type calcium channels are involved in hypoxic pulmonary hypertension.
Cardiovasc. Res.,
2014
Sep
1
, 103 (597-606).
63
Ayoola C
et al.
Inhibition of CaV3.2 T-type calcium channels in peripheral sensory neurons contributes to analgesic properties of epipregnanolone.
Psychopharmacology (Berl.),
2014
Sep
, 231 (3503-15).
64
Cazade M
et al.
5,6-EET potently inhibits T-type calcium channels: implication in the regulation of the vascular tone.
Pflugers Arch.,
2014
Sep
, 466 (1759-68).
65
Zhang Y
et al.
Peripheral pain is enhanced by insulin-like growth factor 1 through a G protein-mediated stimulation of T-type calcium channels.
Sci Signal,
2014
Oct
7
, 7 (ra94).
66
Ranzato E
et al.
Epigallocatechin-3-gallate elicits Ca2+ spike in MCF-7 breast cancer cells: essential role of Cav3.2 channels.
Cell Calcium,
2014
Oct
, 56 (285-95).
67
Felizola SJ
et al.
Voltage-gated calcium channels in the human adrenal and primary aldosteronism.
J. Steroid Biochem. Mol. Biol.,
2014
Oct
, 144 Pt B (410-6).
68
Horibe S
et al.
Ni(2+)-sensitive T-type Ca(2+) channel currents are regulated in parallel with synaptic and visual response plasticity in visual cortex.
Neurosci. Res.,
2014
Oct
, 87 (33-9).
69
Hu CW
et al.
Bone morphogenetic protein-4 induces upregulation of Cav3.1 Ca²⁺ channels in HL-1 atrial myocytes.
Pflugers Arch.,
2014
Nov
, 466 (2049-57).
70
Lin SS
et al.
Cav3.2 T-type calcium channel is required for the NFAT-dependent Sox9 expression in tracheal cartilage.
Proc. Natl. Acad. Sci. U.S.A.,
2014
May
13
, 111 (E1990-8).
71
Perissinotti PP
et al.
Down-regulation of endogenous KLHL1 decreases voltage-gated calcium current density.
Cell Calcium,
2014
May
, 55 (269-80).
72
González-Ramírez R
et al.
Transcription factor Sp1 regulates T-type Ca(2+) channel CaV 3.1 gene expression.
J. Cell. Physiol.,
2014
May
, 229 (551-60).
73
74
Kuryshev YA
et al.
Evaluating state dependence and subtype selectivity of calcium channel modulators in automated electrophysiology assays.
Assay Drug Dev Technol,
2014
Mar
, 12 (110-9).
75
Jarvis MF
et al.
A peripherally acting, selective T-type calcium channel blocker, ABT-639, effectively reduces nociceptive and neuropathic pain in rats.
Biochem. Pharmacol.,
2014
Jun
15
, 89 (536-44).
76
Alday A
et al.
Ionic channels underlying the ventricular action potential in zebrafish embryo.
Pharmacol. Res.,
2014
Jun
, 84 (26-31).
77
Tektürk P
et al.
Calcium channel antibodies in patients with absence epilepsy.
Int. J. Neurosci.,
2014
Jul
, 124 (486-90).
78
Kerckhove N
et al.
Cav3.2 calcium channels: the key protagonist of the supraspinal effect of paracetamol.
Pain,
2014
Jan
18
, ().
79
Zaman T
et al.
LMO4 is essential for paraventricular hypothalamic neuronal activity and calcium channel expression to prevent hyperphagia.
J. Neurosci.,
2014
Jan
1
, 34 (140-8).
80
Cui Y
et al.
Exposure to extremely low-frequency electromagnetic fields inhibits T-type calcium channels via AA/LTE4 signaling pathway.
Cell Calcium,
2014
Jan
, 55 (48-58).
81
Sekiguchi F
et al.
Endogenous and exogenous hydrogen sulfide facilitates T-type calcium channel currents in Cav3.2-expressing HEK293 cells.
Biochem. Biophys. Res. Commun.,
2014
Feb
28
, 445 (225-9).
82
Eckle VS
et al.
Mechanisms by which a CACNA1H mutation in epilepsy patients increases seizure susceptibility.
J. Physiol. (Lond.),
2014
Feb
15
, 592 (795-809).
83
Michaela P
et al.
Bisphenol A differently inhibits CaV3.1, Ca V3.2 and Ca V3.3 calcium channels.
Naunyn Schmiedebergs Arch. Pharmacol.,
2014
Feb
, 387 (153-63).
84
Powell KL
et al.
Seizure expression, behavior, and brain morphology differences in colonies of Genetic Absence Epilepsy Rats from Strasbourg.
Epilepsia,
2014
Dec
, 55 (1959-68).
85
Elíes J
et al.
Hydrogen sulfide inhibits Cav3.2 T-type Ca2+ channels.
FASEB J.,
2014
Dec
, 28 (5376-87).
86
Thuesen AD
et al.
Differential effect of T-type voltage-gated Ca2+ channel disruption on renal plasma flow and glomerular filtration rate in vivo.
Am. J. Physiol. Renal Physiol.,
2014
Aug
15
, 307 (F445-52).
87
Lee SE
et al.
Rebound burst firing in the reticular thalamus is not essential for pharmacological absence seizures in mice.
Proc. Natl. Acad. Sci. U.S.A.,
2014
Aug
12
, 111 (11828-33).
88
Riegle MA
et al.
Ethosuximide reduces electrographical and behavioral correlates of alcohol withdrawal seizure in DBA/2J mice.
Alcohol,
2014
Aug
, 48 (445-53).
89
Zheng H
et al.
Expression and function of a T-type Ca2+ conductance in interstitial cells of Cajal of the murine small intestine.
Am. J. Physiol., Cell Physiol.,
2014
Apr
1
, 306 (C705-13).
90
Kuo IY
et al.
Role of T-type channels in vasomotor function: team player or chameleon?
Pflugers Arch.,
2014
Apr
, 466 (767-79).
91
Perez-Reyes E
et al.
Ins and outs of T-channel structure function.
Pflugers Arch.,
2014
Apr
, 466 (627-33).
92
Carbone E
et al.
T-type channel-mediated neurotransmitter release.
Pflugers Arch.,
2014
Apr
, 466 (677-87).
93
Chemin J
et al.
Modulation of T-type calcium channels by bioactive lipids.
Pflugers Arch.,
2014
Apr
, 466 (689-700).
94
Todorovic SM
et al.
Targeting of CaV3.2 T-type calcium channels in peripheral sensory neurons for the treatment of painful diabetic neuropathy.
Pflugers Arch.,
2014
Apr
, 466 (701-6).
95
Shuba YM
Models of calcium permeation through T-type channels.
Pflugers Arch.,
2014
Apr
, 466 (635-44).
96
Tevoufouet EE
et al.
Cardiac functions of voltage-gated Ca(2+) channels: role of the pharmacoresistant type (E-/R-Type) in cardiac modulation and putative implication in sudden unexpected death in epilepsy (SUDEP).
Rev. Physiol. Biochem. Pharmacol.,
2014
, 167 (115-39).
97
Cioli C
et al.
Differences in human cortical gene expression match the temporal properties of large-scale functional networks.
PLoS ONE,
2014
, 9 (e115913).
98
Gangarossa G
et al.
T-type calcium channel Cav3.2 deficient mice show elevated anxiety, impaired memory and reduced sensitivity to psychostimulants.
Front Behav Neurosci,
2014
, 8 (92).
99
Bladen C
et al.
Block of T-type calcium channels by protoxins I and II.
Mol Brain,
2014
, 7 (36).
100
Obradović ALj
et al.
CaV3.2 T-type calcium channels in peripheral sensory neurons are important for mibefradil-induced reversal of hyperalgesia and allodynia in rats with painful diabetic neuropathy.
PLoS ONE,
2014
, 9 (e91467).
101
Berger ND
et al.
NMP-7 inhibits chronic inflammatory and neuropathic pain via block of Cav3.2 T-type calcium channels and activation of CB2 receptors.
Mol Pain,
2014
, 10 (77).
102
Elies J
et al.
OP20 Inhibition of recombinant T-type Ca(2+) channels by hydrogen sulfide.
Nitric Oxide,
2013
Sep
1
, 31 Suppl 2 (S27-8).
103
Uchino T
et al.
Window current through the T-type Ca2+ channel triggers the mechanism for cellular apoptosis via mitochondrial pathways.
Heart Vessels,
2013
Sep
, 28 (658-66).
104
Wu Z
et al.
Full-length membrane-bound tumor necrosis factor-α acts through tumor necrosis factor receptor 2 to modify phenotype of sensory neurons.
Pain,
2013
Sep
, 154 (1778-82).
105
Senadheera S
et al.
Enhanced contractility in pregnancy is associated with augmented TRPC3, L-type, and T-type voltage-dependent calcium channel function in rat uterine radial artery.
Am. J. Physiol. Regul. Integr. Comp. Physiol.,
2013
Oct
15
, 305 (R917-26).
106
Demers-Giroux PO
et al.
Cooperative activation of the T-type CaV3.2 channel: interaction between Domains II and III.
J. Biol. Chem.,
2013
Oct
11
, 288 (29281-93).
107
Rose KE
et al.
Immunohistological demonstration of CaV3.2 T-type voltage-gated calcium channel expression in soma of dorsal root ganglion neurons and peripheral axons of rat and mouse.
Neuroscience,
2013
Oct
10
, 250 (263-74).
108
Lee J
et al.
Redox mechanism of S-nitrosothiol modulation of neuronal CaV3.2 T-type calcium channels.
Mol. Neurobiol.,
2013
Oct
, 48 (274-80).
109
Rozanski GM
et al.
Low voltage-activated calcium channels gate transmitter release at the dorsal root ganglion sandwich synapse.
J. Physiol. (Lond.),
2013
Nov
15
, 591 (5575-83).
110
Hsu SC
et al.
Early growth response 1 is an early signal inducing Cav3.2 T-type calcium channels during cardiac hypertrophy.
Cardiovasc. Res.,
2013
Nov
1
, 100 (222-30).
111
Seo H
et al.
Effects of eugenol on T-type Ca2+ channel isoforms.
J. Pharmacol. Exp. Ther.,
2013
Nov
, 347 (310-7).
112
Orestes P
et al.
Reversal of neuropathic pain in diabetes by targeting glycosylation of Ca(V)3.2 T-type calcium channels.
Diabetes,
2013
Nov
, 62 (3828-38).
113
Gouriou Y
et al.
Mitochondrial Ca2+ uptake from plasma membrane Cav3.2 protein channels contributes to ischemic toxicity in PC12 cells.
J. Biol. Chem.,
2013
May
3
, 288 (12459-68).
114
Nosal OV
et al.
Complex modulation of Ca(v)3.1 T-type calcium channel by nickel.
Cell. Mol. Life Sci.,
2013
May
, 70 (1653-61).
115
Khomula EV
et al.
Specific functioning of Cav3.2 T-type calcium and TRPV1 channels under different types of STZ-diabetic neuropathy.
Biochim. Biophys. Acta,
2013
May
, 1832 (636-49).
116
Yue J
et al.
Upregulation of T-type Ca2+ channels in primary sensory neurons in spinal nerve injury.
Spine,
2013
Mar
15
, 38 (463-70).
117
Huang CH
et al.
Physical interaction between calcineurin and Cav3.2 T-type Ca2+ channel modulates their functions.
FEBS Lett.,
2013
Jun
19
, 587 (1723-30).
118
Howitt L
et al.
Chronic deficit in nitric oxide elicits oxidative stress and augments T-type calcium-channel contribution to vascular tone of rodent arteries and arterioles.
Cardiovasc. Res.,
2013
Jun
1
, 98 (449-57).
119
Albéri L
et al.
The calcium-binding protein parvalbumin modulates the firing 1 properties of the reticular thalamic nucleus bursting neurons.
J. Neurophysiol.,
2013
Jun
, 109 (2827-41).
120
Park HJ
et al.
Asp residues of the Glu-Glu-Asp-Asp pore filter contribute to ion permeation and selectivity of the Cav3.2 T-type channel.
Cell Calcium,
2013
Jul
9
, ().
121
Engbers JD
et al.
Modeling interactions between voltage-gated Ca ( 2+) channels and KCa1.1 channels.
Channels (Austin),
2013
Jul
31
, 7 ().
122
Harraz OF
et al.
Protein kinase A regulation of T-type Ca2+ channels in rat cerebral arterial smooth muscle.
J. Cell. Sci.,
2013
Jul
1
, 126 (2944-54).
123
Todorovic SM
et al.
Neuropathic pain: role for presynaptic T-type channels in nociceptive signaling.
Pflugers Arch.,
2013
Jul
, 465 (921-7).
124
Zhang Y
et al.
Modulation of low-voltage-activated T-type Ca²⁺ channels.
Biochim. Biophys. Acta,
2013
Jul
, 1828 (1550-9).
125
Wan J
et al.
Chronic hypoxia selectively enhances L- and T-type voltage-dependent Ca2+ channel activity in pulmonary artery by upregulating Cav1.2 and Cav3.2.
Am. J. Physiol. Lung Cell Mol. Physiol.,
2013
Jul
, 305 (L154-64).
126
Abd El-Rahman RR
et al.
Identification of L- and T-type Ca2+ channels in rat cerebral arteries: role in myogenic tone development.
Am. J. Physiol. Heart Circ. Physiol.,
2013
Jan
1
, 304 (H58-71).
127
Giordanetto F
et al.
Discovery of N-[[1-[2-(tert-butylcarbamoylamino)ethyl]-4-(hydroxymethyl)-4-piperidyl]methyl]-3,5-dichloro-benzamide as a selective T-type calcium channel (Ca(v)3.2) inhibitor.
Bioorg. Med. Chem. Lett.,
2013
Jan
1
, 23 (119-24).
128
Kürtüncü M
et al.
CACNA1H antibodies associated with headache with neurological deficits and cerebrospinal fluid lymphocytosis (HaNDL).
Cephalalgia,
2013
Jan
, 33 (123-9).
129
Kawabata A
[Targeting Ca(v)3.2 T-type calcium channels as a therapeutic strategy for chemotherapy-induced neuropathic pain].
Nippon Yakurigaku Zasshi,
2013
Feb
, 141 (81-4).
130
Shan HQ
et al.
Ethanol inhibition of a T-type Ca²+ channel through activity of protein kinase C.
Alcohol. Clin. Exp. Res.,
2013
Aug
, 37 (1333-42).
131
Boycott HE
et al.
Carbon monoxide inhibition of Cav3.2 T-type Ca2+ channels reveals tonic modulation by thioredoxin.
FASEB J.,
2013
Aug
, 27 (3395-407).
132
Enyeart JJ
et al.
Ca2+ and K+ channels of normal human adrenal zona fasciculata cells: properties and modulation by ACTH and AngII.
J. Gen. Physiol.,
2013
Aug
, 142 (137-55).
133
Weiss N
et al.
Surface expression and function of Cav3.2 T-type calcium channels are controlled by asparagine-linked glycosylation.
Pflugers Arch.,
2013
Aug
, 465 (1159-70).
134
Sekiguchi F
et al.
T-type calcium channels: functional regulation and implication in pain signaling.
J. Pharmacol. Sci.,
2013
, 122 (244-50).
135
Brennan SC
et al.
Fetal calcium regulates branching morphogenesis in the developing human and mouse lung: involvement of voltage-gated calcium channels.
PLoS ONE,
2013
, 8 (e80294).
136
Atkinson AJ
et al.
Functional, anatomical, and molecular investigation of the cardiac conduction system and arrhythmogenic atrioventricular ring tissue in the rat heart.
J Am Heart Assoc,
2013
, 2 (e000246).
137
Gadotti VM
et al.
Analgesic effect of a mixed T-type channel inhibitor/CB2 receptor agonist.
Mol Pain,
2013
, 9 (32).
138
Mahapatra S
et al.
Calcium channel types contributing to chromaffin cell excitability, exocytosis and endocytosis.
Cell Calcium,
2012 Mar-Apr
, 51 (321-30).
139
Bladen C
et al.
Common mechanisms of drug interactions with sodium and T-type calcium channels.
Mol. Pharmacol.,
2012
Sep
, 82 (481-7).
140
Lopez-Charcas O
et al.
Block of human CaV3 channels by the diuretic amiloride.
Mol. Pharmacol.,
2012
Oct
, 82 (658-67).
141
Cui J
et al.
Expression of CaV3.2 T-type Ca²⁺ channels in a subpopulation of retinal type-3 cone bipolar cells.
Neuroscience,
2012
Nov
8
, 224 (63-9).
142
Francois A
et al.
State-dependent properties of a new T-type calcium channel blocker enhance Ca(V)3.2 selectivity and support analgesic effects.
Pain,
2012
Nov
5
, ().
143
van Loo KM
et al.
Transcriptional regulation of T-type calcium channel CaV3.2: bi-directionality by early growth response 1 (Egr1) and repressor element 1 (RE-1) protein-silencing transcription factor (REST).
J. Biol. Chem.,
2012
May
4
, 287 (15489-501).
144
Chevalier M
et al.
Dehydroepiandrosterone (DHEA) inhibits voltage-gated T-type calcium channels.
,
2012
Mar
3
, ().
145
Tao J
et al.
Effects of familial hemiplegic migraine type 1 mutation T666M on voltage-gated calcium channel activities in trigeminal ganglion neurons.
J. Neurophysiol.,
2012
Mar
, 107 (1666-80).
146
Balderas E
et al.
Niflumic acid blocks native and recombinant T-type channels.
J. Cell. Physiol.,
2012
Jun
, 227 (2542-55).
147
Gönczi M
et al.
Age-dependent changes in ion channel mRNA expression in canine cardiac tissues.
Gen. Physiol. Biophys.,
2012
Jun
, 31 (153-62).
148
Jacus MO
et al.
Presynaptic Cav3.2 channels regulate excitatory neurotransmission in nociceptive dorsal horn neurons.
J. Neurosci.,
2012
Jul
4
, 32 (9374-82).
149
Mor M
et al.
ZnT-1 enhances the activity and surface expression of T-type calcium channels through activation of Ras-ERK signaling.
Am. J. Physiol., Cell Physiol.,
2012
Jul
15
, 303 (C192-203).
150
Okubo K
et al.
Hydrogen sulfide-induced mechanical hyperalgesia and allodynia require activation of both Cav3.2 and TRPA1 channels in mice.
Br. J. Pharmacol.,
2012
Jul
, 166 (1738-43).
151
Li CX
et al.
[Distribution diversity of integrins and calcium channels on major human and mouse host cells of Leptospira species].
Zhejiang Da Xue Xue Bao Yi Xue Ban,
2012
Jul
, 41 (410-7).
152
Ohkubo T
et al.
T-type voltage-activated calcium channel Cav3.1, but not Cav3.2, is involved in the inhibition of proliferation and apoptosis in MCF-7 human breast cancer cells.
Int. J. Oncol.,
2012
Jul
, 41 (267-75).
153
Weiss N
et al.
A Ca(v)3.2/syntaxin-1A signaling complex controls T-type channel activity and low-threshold exocytosis.
J. Biol. Chem.,
2012
Jan
20
, 287 (2810-8).
154
Zhang Y
et al.
Inhibition of T-type Ca(2+) channels by endostatin attenuates human glioblastoma cell proliferation and migration.
,
2012
Jan
10
, ().
155
Bolaños-Jiménez R
et al.
Mice mechanoreceptors are modulated by Ca(v)3.2 T-type calcium channels.
J. Physiol. (Lond.),
2012
Jan
1
, 590 (7).
156
Hilaire C
et al.
Neurotrophin-4 modulates the mechanotransducer Cav3.2 T-type calcium current in mice down-hair neurons.
Biochem. J.,
2012
Jan
1
, 441 (463-71).
157
Engbers JD
et al.
Intermediate conductance calcium-activated potassium channels modulate summation of parallel fiber input in cerebellar Purkinje cells.
Proc. Natl. Acad. Sci. U.S.A.,
2012
Feb
14
, 109 (2601-6).
158
Matsunami M
et al.
Hydrogen sulfide-induced colonic mucosal cytoprotection involves T-type calcium channel-dependent neuronal excitation in rats.
J. Physiol. Pharmacol.,
2012
Feb
, 63 (61-8).
159
Schweikart K
et al.
The effects of jaspamide on human cardiomyocyte function and cardiac ion channel activity.
Toxicol In Vitro,
2012
Dec
20
, 27 (745-751).
160
Tzeng BH
et al.
The Ca(v)3.1 T-type calcium channel is required for neointimal formation in response to vascular injury in mice.
Cardiovasc. Res.,
2012
Dec
1
, 96 (533-42).
161
Li Y
et al.
β-Adrenergic stimulation increases Cav3.1 activity in cardiac myocytes through protein kinase A.
PLoS ONE,
2012
, 7 (e39965).
162
Chen CC
et al.
Retrieval of context-associated memory is dependent on the Ca(v)3.2 T-type calcium channel.
PLoS ONE,
2012
, 7 (e29384).
163
Tsubota-Matsunami M
et al.
Colonic hydrogen sulfide-induced visceral pain and referred hyperalgesia involve activation of both Ca(v)3.2 and TRPA1 channels in mice.
J. Pharmacol. Sci.,
2012
, 119 (293-6).
164
Giordanetto F
et al.
Discovery of N-(1-adamantyl)-2-(4-alkylpiperazin-1-yl)acetamide derivatives as T-type calcium channel (Cav3.2) inhibitors.
Bioorg. Med. Chem. Lett.,
2011
Sep
15
, 21 (5557-61).
165
Thompson WR
et al.
Association of the α(2)δ(1) subunit with Ca(v)3.2 enhances membrane expression and regulates mechanically induced ATP release in MLO-Y4 osteocytes.
J. Bone Miner. Res.,
2011
Sep
, 26 (2125-39).
166
167
Bahrudin U
et al.
Impairment of ubiquitin-proteasome system by E334K cMyBPC modifies channel proteins, leading to electrophysiological dysfunction.
J. Mol. Biol.,
2011
Nov
4
, 413 (857-78).
168
Rodriguez-Gomez JA
et al.
T-type Ca2+ channels in mouse embryonic stem cells: modulation during cell cycle and contribution to self-renewal.
,
2011
Nov
2
, ().
169
Alnawaiseh M
et al.
Two separate Ni(2+) -sensitive voltage-gated Ca(2+) channels modulate transretinal signalling in the isolated murine retina.
Acta Ophthalmol,
2011
Nov
, 89 (e579-90).
170
Enyeart JA
et al.
8-Phenylthio-adenines stimulate the expression of steroid hydroxylases, Cav3.2 Ca²⁺ channels, and cortisol synthesis by a cAMP-independent mechanism.
Am. J. Physiol. Endocrinol. Metab.,
2011
Nov
, 301 (E941-54).
171
Choe W
et al.
TTA-P2 is a potent and selective blocker of T-type calcium channels in rat sensory neurons and a novel antinociceptive agent.
Mol. Pharmacol.,
2011
Nov
, 80 (900-10).
172
Cao XH
et al.
Diabetic neuropathy enhances voltage-activated Ca2+ channel activity and its control by M4 muscarinic receptors in primary sensory neurons.
J. Neurochem.,
2011
Nov
, 119 (594-603).
173
Inayoshi A
et al.
Mechanism underlying the block of human Cav3.2 T-type Ca2+ channels by benidipine, a dihydropyridine Ca2+ channel blocker.
Life Sci.,
2011
May
9
, 88 (898-907).
174
Matsunami M
et al.
Chelating luminal zinc mimics hydrogen sulfide-evoked colonic pain in mice: possible involvement of T-type calcium channels.
Neuroscience,
2011
May
5
, 181 (257-64).
175
Wang R
et al.
The Cav3.2 T-type calcium channel regulates temporal coding in mouse mechanoreceptors.
J. Physiol. (Lond.),
2011
May
1
, 589 (2229-43).
176
Howarth FC
et al.
Changing pattern of gene expression is associated with ventricular myocyte dysfunction and altered mechanisms of Ca2+ signalling in young type 2 Zucker diabetic fatty rat heart.
Exp. Physiol.,
2011
Mar
, 96 (325-37).
177
Marger F
et al.
T-type calcium channels contribute to colonic hypersensitivity in a rat model of irritable bowel syndrome.
Proc. Natl. Acad. Sci. U.S.A.,
2011
Jul
5
, 108 (11268-73).
178
Huang Z
et al.
Presynaptic HCN1 channels regulate Ca(V)3.2 activity and neurotransmission at select cortical synapses.
,
2011
Feb
27
, ().
179
Hildebrand ME
et al.
A novel slow-inactivation-specific ion channel modulator attenuates neuropathic pain.
,
2011
Feb
22
, ().
180
Poulsen CB
et al.
T-type voltage-gated calcium channels regulate the tone of mouse efferent arterioles.
Kidney Int.,
2011
Feb
, 79 (443-51).
181
Hill J
et al.
Pituitary adenylate cyclase-activating peptide (PACAP) recruits low voltage-activated T-type calcium influx under acute sympathetic stimulation in mouse adrenal chromaffin cells.
J. Biol. Chem.,
2011
Dec
9
, 286 (42459-69).
182
Yalçın O
Genes and molecular mechanisms involved in the epileptogenesis of idiopathic absence epilepsies.
,
2011
Dec
27
, ().
183
Liu G
et al.
[Regulation of T-type Ca(2+) channel in lysophosphatidylcholine-stimulated cardiomyocytes].
Beijing Da Xue Xue Bao,
2011
Dec
18
, 43 (804-8).
184
Lacinová L
T-type calcium channel blockers - new and notable.
Gen. Physiol. Biophys.,
2011
Dec
, 30 (403-9).
185
Astori S
et al.
The Ca(V)3.3 calcium channel is the major sleep spindle pacemaker in thalamus.
Proc. Natl. Acad. Sci. U.S.A.,
2011
Aug
16
, 108 (13823-8).
186
Okubo K
et al.
Inhibition of T-type calcium channels and hydrogen sulfide-forming enzyme reverses paclitaxel-evoked neuropathic hyperalgesia in rats.
Neuroscience,
2011
Aug
11
, 188 (148-56).
187
Le Quang K
et al.
Role of T-type calcium channel subunits in post-myocardial infarction remodelling probed with genetically engineered mice.
Cardiovasc. Res.,
2011
Aug
1
, 91 (420-8).
188
Lei D
et al.
Anti-epileptic drugs delay age-related loss of spiral ganglion neurons via T-type calcium channel.
Hear. Res.,
2011
Aug
, 278 (106-12).
189
You H
et al.
Functional characterization and analgesic effects of mixed cannabinoid receptor/T-type channel ligands.
Mol Pain,
2011
, 7 (89).
190
Liao YF
et al.
Involvement of the Cav3.2 T-type calcium channel in thalamic neuron discharge patterns.
Mol Pain,
2011
, 7 (43).
191
Wang Q
et al.
Effects of raloxifene on voltage-dependent T-type Ca2+ channels in mouse spermatogenic cells.
Pharmacology,
2011
, 87 (70-80).
192
David LS
et al.
Splice-variant changes of the Ca(V)3.2 T-type calcium channel mediate voltage-dependent facilitation and associate with cardiac hypertrophy and development.
Channels (Austin),
2010 Sep-Oct
, 4 (375-89).
193
Cribbs L
T-type calcium channel expression and function in the diseased heart.
Channels (Austin),
2010 Nov-Dec
, 4 (447-52).
194
Cain SM
et al.
Contributions of T-type calcium channel isoforms to neuronal firing.
Channels (Austin),
2010 Nov-Dec
, 4 (475-82).
195
Perez-Reyes E
Characterization of the gating brake in the I-II loop of CaV3 T-type calcium channels.
Channels (Austin),
2010 Nov-Dec
, 4 (453-8).
196
Anderson D
et al.
Regulation of the KV4.2 complex by CaV3.1 calcium channels.
Channels (Austin),
2010 May-Jun
, 4 (163-7).
197
Orestes P
et al.
Free radical signaling underlies inhibition of CaV3.2 T-type calcium channels by nitrous oxide in the pain pathway.
,
2010
Nov
8
, ().
198
Markandeya YS
et al.
Caveolin-3 regulates the protein kinase A modulation of CaV3.2 ({alpha}1H) T-type Ca2+ channels.
,
2010
Nov
17
, ().
199
Ou Y
et al.
Expression of key ion channels in the rat cardiac conduction system by laser capture microdissection and qPCR.
,
2010
May
28
, ().
200
Prigge M
et al.
Fast, repetitive light-activation of Ca(V)3.2 using channelrhodopsin 2.
,
2010
May
25
, 4 ().
201
Strege PR
et al.
T-type Ca(2+) channel modulation by otilonium bromide.
Am. J. Physiol. Gastrointest. Liver Physiol.,
2010
May
, 298 (G706-13).
202
Thévenod F
Catch me if you can! Novel aspects of cadmium transport in mammalian cells.
,
2010
Mar
5
, ().
203
Liu H
et al.
ACTH induces Cav3.2 current and mRNA by cAMP-dependent and cAMP-independent mechanisms.
J. Biol. Chem.,
2010
Jun
25
, 285 (20040-50).
204
Aromolaran KA
et al.
T-type current modulation by the actin-binding protein Kelch-like 1.
Am. J. Physiol., Cell Physiol.,
2010
Jun
, 298 (C1353-62).
205
Kuo IY
et al.
Dihydropyridine-insensitive calcium currents contribute to function of small cerebral arteries.
J. Cereb. Blood Flow Metab.,
2010
Jun
, 30 (1226-39).
206
Omatsu-Kanbe M
et al.
Self-beating atypically shaped cardiomyocytes survive a long-term postnatal development while preserving the expression of fetal cardiac genes in mice.
J. Histochem. Cytochem.,
2010
Jun
, 58 (543-51).
207
Takahashi T
et al.
Upregulation of Ca(v)3.2 T-type calcium channels targeted by endogenous hydrogen sulfide contributes to maintenance of neuropathic pain.
Pain,
2010
Jul
, 150 (183-91).
208
Tarui T
et al.
Involvement of Src kinase in T-type calcium channel-dependent neuronal differentiation of NG108-15 cells by hydrogen sulfide.
J. Neurochem.,
2010
Jul
, 114 (512-9).
209
Kang HW
et al.
Structural determinants of the high affinity extracellular zinc binding site on Cav3.2 T-type calcium channels.
J. Biol. Chem.,
2010
Jan
29
, 285 (3271-81).
210
Ono K
et al.
Cardiac T-type Ca(2+) channels in the heart.
J. Mol. Cell. Cardiol.,
2010
Jan
, 48 (65-70).
211
Zheng M
et al.
Intracellular Ca(2+)- and PKC-dependent upregulation of T-type Ca(2+) channels in LPC-stimulated cardiomyocytes.
J. Mol. Cell. Cardiol.,
2010
Jan
, 48 (131-9).
212
Rangel A
et al.
Protein kinase C-mediated inhibition of recombinant T-type Cav3.2 channels by neurokinin 1 receptors.
Mol. Pharmacol.,
2010
Feb
, 77 (202-10).
213
Perez-Reyes E
G protein-mediated inhibition of Cav3.2 T-type channels revisited.
Mol. Pharmacol.,
2010
Feb
, 77 (136-8).
214
You H
et al.
CCR2 receptor ligands inhibit Cav3.2 T-type calcium channels.
Mol. Pharmacol.,
2010
Feb
, 77 (211-7).
215
Chen WK
et al.
Ca(v)3.2 T-type Ca2+ channel-dependent activation of ERK in paraventricular thalamus modulates acid-induced chronic muscle pain.
J. Neurosci.,
2010
Aug
4
, 30 (10360-8).
216
Souvannakitti D
et al.
NADPH oxidase-dependent regulation of T-type Ca2+ channels and ryanodine receptors mediate the augmented exocytosis of catecholamines from intermittent hypoxia-treated neonatal rat chromaffin cells.
J. Neurosci.,
2010
Aug
11
, 30 (10763-72).
217
Smith EM
et al.
T-type calcium channel blockers: spiro-piperidine azetidines and azetidinones-optimization, design and synthesis.
Bioorg. Med. Chem. Lett.,
2010
Aug
1
, 20 (4602-6).
218
Wen XJ
et al.
The roles of T-type calcium channel in the development of neuropathic pain following chronic compression of rat dorsal root ganglia.
Pharmacology,
2010
, 85 (295-300).
219
Mizuta E
et al.
Different distribution of Cav3.2 and Cav3.1 transcripts encoding T-type Ca(2+) channels in the embryonic heart of mice.
Biomed. Res.,
2010
, 31 (301-5).
220
Liang H
et al.
Electrophysiological basis of the first heart beats.
Cell. Physiol. Biochem.,
2010
, 25 (561-70).
221
Gibbons SJ
et al.
The alpha1H Ca2+ channel subunit is expressed in mouse jejunal interstitial cells of Cajal and myocytes.
J. Cell. Mol. Med.,
2009 Nov-Dec
, 13 (4422-31).
222
Barbara G
et al.
T-type calcium channel inhibition underlies the analgesic effects of the endogenous lipoamino acids.
J. Neurosci.,
2009
Oct
21
, 29 (13106-14).
223
Lewis BB
et al.
Cloning and characterization of voltage-gated calcium channel alpha1 subunits in Xenopus laevis during development.
Dev. Dyn.,
2009
Nov
, 238 (2891-902).
224
Aromolaran KA
et al.
Kelch-like 1 protein upregulates T-type currents by an actin-F dependent increase in α(1H) channels via the recycling endosome.
Channels (Austin),
2009
Nov
, 3 (402-12).
225
Braun AP
Convergent signaling events underlie dopamine-mediated inhibition of CaV3.2 T-type calcium channels.
Channels (Austin),
2009
Nov
, 3 (381-2).
226
Hu C
et al.
Protein kinase A activity controls the regulation of T-type CaV3.2 channels by Gbetagamma dimers.
J. Biol. Chem.,
2009
Mar
20
, 284 (7465-73).
227
Maeda Y
et al.
Hyperalgesia induced by spinal and peripheral hydrogen sulfide: evidence for involvement of Cav3.2 T-type calcium channels.
Pain,
2009
Mar
, 142 (127-32).
228
Somekawa S
et al.
Regulation of aldosterone and cortisol production by the transcriptional repressor neuron restrictive silencer factor.
Endocrinology,
2009
Jul
, 150 (3110-7).
229
Bosch MA
et al.
17Beta-estradiol regulation of the mRNA expression of T-type calcium channel subunits: role of estrogen receptor alpha and estrogen receptor beta.
J. Comp. Neurol.,
2009
Jan
20
, 512 (347-58).
230
Masuda T
et al.
Laser capture microdissection and cDNA array analysis for identification of mouse KIAA/FLJ genes differentially expressed in the embryonic dorsal spinal cord.
Brain Res.,
2009
Jan
16
, 1249 (61-7).
231
Powell KL
et al.
A Cav3.2 T-type calcium channel point mutation has splice-variant-specific effects on function and segregates with seizure expression in a polygenic rat model of absence epilepsy.
J. Neurosci.,
2009
Jan
14
, 29 (371-80).
232
Jensen LJ
et al.
Is there a role for T-type Ca2+ channels in regulation of vasomotor tone in mesenteric arterioles?
Can. J. Physiol. Pharmacol.,
2009
Jan
, 87 (8-20).
233
Perez-Reyes E
et al.
Molecular pharmacology of human Cav3.2 T-type Ca2+ channels: block by antihypertensives, antiarrhythmics, and their analogs.
J. Pharmacol. Exp. Ther.,
2009
Feb
, 328 (621-7).
234
Koyama T
et al.
Molecular and electrical remodeling of L- and T-type Ca(2+) channels in rat right atrium with monocrotaline-induced pulmonary hypertension.
Circ. J.,
2009
Feb
, 73 (256-63).
235
Tao J
et al.
Tyrosine kinase-independent inhibition by genistein on spermatogenic T-type calcium channels attenuates mouse sperm motility and acrosome reaction.
Cell Calcium,
2009
Feb
, 45 (133-43).
236
Wu ZZ
et al.
Aminopyridines potentiate synaptic and neuromuscular transmission by targeting the voltage-activated calcium channel beta subunit.
J. Biol. Chem.,
2009
Dec
25
, 284 (36453-61).
237
Zamponi GW
et al.
Role of voltage-gated calcium channels in epilepsy.
,
2009
Dec
20
, ().
238
Zhang C
et al.
17Beta-estradiol regulation of T-type calcium channels in gonadotropin-releasing hormone neurons.
J. Neurosci.,
2009
Aug
26
, 29 (10552-62).
239
Maturana A
et al.
Role of the T-type calcium channel CaV3.2 in the chronotropic action of corticosteroids in isolated rat ventricular myocytes.
Endocrinology,
2009
Aug
, 150 (3726-34).
240
Mulgrew CJ
et al.
Inhibition of human mesangial cell proliferation by targeting T-type calcium channels.
Nephron Exp. Nephrol.,
2009
, 113 (e77-88).
241
Inagaki A
et al.
The CaV3.1 T-type Ca2+channel contributes to voltage-dependent calcium currents in rat outer hair cells.
Brain Res.,
2008
Mar
27
, 1201 (68-77).
242
Varela DL
et al.
Making the T-type even tinier: corticotropin-releasing factor-mediated inhibition of low-voltage-activated calcium channel activity.
Mol. Pharmacol.,
2008
Jun
, 73 (1589-91).
243
Tao J
et al.
Activation of corticotropin-releasing factor receptor 1 selectively inhibits CaV3.2 T-type calcium channels.
Mol. Pharmacol.,
2008
Jun
, 73 (1596-609).
244
Strube C
Absence of regulation of the T-type calcium current by Cav1.1, beta1a and gamma1 dihydropyridine receptor subunits in skeletal muscle cells.
Pflugers Arch.,
2008
Feb
, 455 (921-7).
245
Huh SU
et al.
Regulation of CA(v)3.2 Ca2+ channel activity by protein tyrosine phosphorylation.
J. Microbiol. Biotechnol.,
2008
Feb
, 18 (365-8).
246
Becker AJ
et al.
Transcriptional upregulation of Cav3.2 mediates epileptogenesis in the pilocarpine model of epilepsy.
J. Neurosci.,
2008
Dec
3
, 28 (13341-53).
247
Kang HW
et al.
Distinct contributions of different structural regions to the current kinetics of the Cav3.3 T-type Ca2+ channel.
Biochim. Biophys. Acta,
2008
Dec
, 1778 (2740-8).
248
Gackière F
et al.
CaV3.2 T-type calcium channels are involved in calcium-dependent secretion of neuroendocrine prostate cancer cells.
J. Biol. Chem.,
2008
Apr
11
, 283 (10162-73).
249
Aptel H
et al.
The Cav3.2/alpha1H T-type Ca2+ current is a molecular determinant of excitatory effects of GABA in adult sensory neurons.
Mol. Cell. Neurosci.,
2007
Oct
, 36 (293-303).
250
Liang J
et al.
Common polymorphisms in the CACNA1H gene associated with childhood absence epilepsy in Chinese Han population.
Ann. Hum. Genet.,
2007
May
, 71 (325-35).
251
Blanks AM
et al.
Characterization of the molecular and electrophysiological properties of the T-type calcium channel in human myometrium.
J. Physiol. (Lond.),
2007
Jun
15
, 581 (915-26).
252
Hildebrand ME
et al.
Selective inhibition of Cav3.3 T-type calcium channels by Galphaq/11-coupled muscarinic acetylcholine receptors.
J. Biol. Chem.,
2007
Jul
20
, 282 (21043-55).
253
Vitko I
et al.
The I-II loop controls plasma membrane expression and gating of Ca(v)3.2 T-type Ca2+ channels: a paradigm for childhood absence epilepsy mutations.
J. Neurosci.,
2007
Jan
10
, 27 (322-30).
254
Traboulsie A
et al.
Subunit-specific modulation of T-type calcium channels by zinc.
J. Physiol. (Lond.),
2007
Jan
1
, 578 (159-71).
255
Coste B
et al.
Pharmacological dissection and distribution of NaN/Nav1.9, T-type Ca2+ currents, and mechanically activated cation currents in different populations of DRG neurons.
J. Gen. Physiol.,
2007
Jan
, 129 (57-77).
256
Kang HW
et al.
Histidine residues in the IS3-IS4 loop are critical for nickel-sensitive inhibition of the Cav2.3 calcium channel.
FEBS Lett.,
2007
Dec
22
, 581 (5774-80).
257
Heron SE
et al.
Extended spectrum of idiopathic generalized epilepsies associated with CACNA1H functional variants.
Ann. Neurol.,
2007
Dec
, 62 (560-8).
258
Sun HS
et al.
Zn2+ sensitivity of high- and low-voltage activated calcium channels.
Biophys. J.,
2007
Aug
15
, 93 (1175-83).
259
Asaga S
et al.
Identification of a new breast cancer-related gene by restriction landmark genomic scanning.
Anticancer Res.,
2006 Jan-Feb
, 26 (35-42).
260
Nordskog BK
et al.
Diurnal gene expression patterns of T-type calcium channels and their modulation by ethanol.
Neuroscience,
2006
Sep
1
, 141 (1365-73).
261
Mathie A
et al.
Zinc and copper: pharmacological probes and endogenous modulators of neuronal excitability.
Pharmacol. Ther.,
2006
Sep
, 111 (567-83).
262
Liang J
et al.
New variants in the CACNA1H gene identified in childhood absence epilepsy.
Neurosci. Lett.,
2006
Oct
2
, 406 (27-32).
263
Avila T
et al.
Transforming growth factor-beta1 and bone morphogenetic protein-2 downregulate CaV3.1 channel expression in mouse C2C12 myoblasts.
J. Cell. Physiol.,
2006
Nov
, 209 (448-56).
264
Zhong X
et al.
A profile of alternative RNA splicing and transcript variation of CACNA1H, a human T-channel gene candidate for idiopathic generalized epilepsies.
Hum. Mol. Genet.,
2006
May
1
, 15 (1497-512).
265
Yamashita N
et al.
Short- and long-term amiodarone treatments regulate Cav3.2 low-voltage-activated T-type Ca2+ channel through distinct mechanisms.
Mol. Pharmacol.,
2006
May
, 69 (1684-91).
266
Chioza B
et al.
Evaluation of CACNA1H in European patients with childhood absence epilepsy.
Epilepsy Res.,
2006
May
, 69 (177-81).
267
Giancippoli A
et al.
Low-threshold exocytosis induced by cAMP-recruited CaV3.2 (alpha1H) channels in rat chromaffin cells.
Biophys. J.,
2006
Mar
1
, 90 (1830-41).
268
Bergh JJ
et al.
Osteoblast Ca(2+) permeability and voltage-sensitive Ca(2+) channel expression is temporally regulated by 1,25-dihydroxyvitamin D(3).
Am. J. Physiol., Cell Physiol.,
2006
Mar
, 290 (C822-31).
269
Peloquin JB
et al.
Functional analysis of Ca3.2 T-type calcium channel mutations linked to childhood absence epilepsy.
Epilepsia,
2006
Mar
, 47 (655-8).
270
Joksovic PM
et al.
CaV3.2 is the major molecular substrate for redox regulation of T-type Ca2+ channels in the rat and mouse thalamus.
J. Physiol. (Lond.),
2006
Jul
15
, 574 (415-30).
271
Kim JA
et al.
Augmentation of Cav3.2 T-type calcium channel activity by cAMP-dependent protein kinase A.
J. Pharmacol. Exp. Ther.,
2006
Jul
, 318 (230-7).
272
Kang HW
et al.
A molecular determinant of nickel inhibition in Cav3.2 T-type calcium channels.
J. Biol. Chem.,
2006
Feb
24
, 281 (4823-30).
273
Mizuta E
et al.
Delayed onset of beating and decreased expression of T-type Ca2+ channel in mouse ES cell-derived cardiocytes carrying human chromosome 21.
Biochem. Biophys. Res. Commun.,
2006
Dec
8
, 351 (126-32).
274
Park JY
et al.
Activation of protein kinase C augments T-type Ca2+ channel activity without changing channel surface density.
J. Physiol. (Lond.),
2006
Dec
1
, 577 (513-23).
275
Wen XJ
et al.
Intrathecal administration of Cav3.2 and Cav3.3 antisense oligonucleotide reverses tactile allodynia and thermal hyperalgesia in rats following chronic compression of dorsal root of ganglion.
Acta Pharmacol. Sin.,
2006
Dec
, 27 (1547-52).
276
Perez-Reyes E
et al.
Molecular biology of T-type calcium channels.
CNS Neurol Disord Drug Targets,
2006
Dec
, 5 (605-9).
277
Lambert RC
et al.
Modulation of neuronal T-type calcium channels.
CNS Neurol Disord Drug Targets,
2006
Dec
, 5 (611-27).
278
Splawski I
et al.
CACNA1H mutations in autism spectrum disorders.
J. Biol. Chem.,
2006
Aug
4
, 281 (22085-91).
279
Wang JL
et al.
[The effect of CACNA1H gene G773D mutation on calcium channel function]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi,
2006
Aug
, 23 (369-73).
280
Chemin J
et al.
Molecular pathways underlying the modulation of T-type calcium channels by neurotransmitters and hormones.
Cell Calcium,
2006
Aug
, 40 (121-34).
281
Lory P
et al.
T-type calcium channels in differentiation and proliferation.
Cell Calcium,
2006
Aug
, 40 (135-46).
282
Talavera K
et al.
Biophysics and structure-function relationship of T-type Ca2+ channels.
Cell Calcium,
2006
Aug
, 40 (97-114).
283
Perez-Reyes E
Molecular characterization of T-type calcium channels.
Cell Calcium,
2006
Aug
, 40 (89-96).
284
Shao Y
et al.
Expression of voltage sensitive calcium channel (VSCC) L-type Cav1.2 (alpha1C) and T-type Cav3.2 (alpha1H) subunits during mouse bone development.
Dev. Dyn.,
2005
Sep
, 234 (54-62).
285
Mulley JC
et al.
Susceptibility genes for complex epilepsy.
Hum. Mol. Genet.,
2005
Oct
15
, 14 Spec No. 2 (R243-9).
286
Mizuta E
et al.
Subtype switching of T-type Ca 2+ channels from Cav3.2 to Cav3.1 during differentiation of embryonic stem cells to cardiac cell lineage.
Circ. J.,
2005
Oct
, 69 (1284-9).
287
Kuwahara K
et al.
Pathophysiological significance of T-type Ca2+ channels: transcriptional regulation of T-type Ca2+ channel--regulation of CACNA1H by neuron-restrictive silencer factor.
J. Pharmacol. Sci.,
2005
Nov
, 99 (211-3).
288
Vitko I
et al.
Functional characterization and neuronal modeling of the effects of childhood absence epilepsy variants of CACNA1H, a T-type calcium channel.
J. Neurosci.,
2005
May
11
, 25 (4844-55).
289
Khosravani H
et al.
Effects of Cav3.2 channel mutations linked to idiopathic generalized epilepsy.
Ann. Neurol.,
2005
May
, 57 (745-9).
290
Uchino T
et al.
Voltage-dependent and frequency-independent inhibition of recombinant Cav3.2 T-type Ca2+ channel by bepridil.
Pharmacology,
2005
Jul
, 74 (174-81).
291
Bourinet E
et al.
Silencing of the Cav3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception.
EMBO J.,
2005
Jan
26
, 24 (315-24).
292
Larsen JK
et al.
Disruption of growth hormone secretion alters Ca2+ current density and expression of Ca2+ channel and insulin-like growth factor genes in rat atria.
Am. J. Physiol. Heart Circ. Physiol.,
2005
Feb
, 288 (H829-38).
293
Brueggemann LI
et al.
Low voltage-activated calcium channels in vascular smooth muscle: T-type channels and AVP-stimulated calcium spiking.
Am. J. Physiol. Heart Circ. Physiol.,
2005
Feb
, 288 (H923-35).
294
Lu JJ
et al.
[T-type calcium channel gene-CACNA1H is a susceptibility gene to childhood absence epilepsy]
Zhonghua Er Ke Za Zhi,
2005
Feb
, 43 (133-6).
295
Autret L
et al.
The involvement of Cav3.2/alpha1H T-type calcium channels in excitability of mouse embryonic primary vestibular neurones.
J. Physiol. (Lond.),
2005
Aug
15
, 567 (67-78).
296
Gardiner M
Genetics of idiopathic generalized epilepsies.
Epilepsia,
2005
, 46 Suppl 9 (15-20).
297
Khosravani H
et al.
Gating effects of mutations in the Cav3.2 T-type calcium channel associated with childhood absence epilepsy.
J. Biol. Chem.,
2004
Mar
12
, 279 (9681-4).
298
Niwa N
et al.
Cav3.2 subunit underlies the functional T-type Ca2+ channel in murine hearts during the embryonic period.
Am. J. Physiol. Heart Circ. Physiol.,
2004
Jun
, 286 (H2257-63).
299
Stamboulian S
et al.
Biophysical and pharmacological characterization of spermatogenic T-type calcium current in mice lacking the CaV3.1 (alpha1G) calcium channel: CaV3.2 (alpha1H) is the main functional calcium channel in wild-type spermatogenic cells.
J. Cell. Physiol.,
2004
Jul
, 200 (116-24).
300
Gray LS
et al.
The role of voltage gated T-type Ca2+ channel isoforms in mediating "capacitative" Ca2+ entry in cancer cells.
Cell Calcium,
2004
Dec
, 36 (489-97).
301
Yoshida M
et al.
Aberrant expression of the MEL1S gene identified in association with hypomethylation in adult T-cell leukemia cells.
Blood,
2004
Apr
1
, 103 (2753-60).
302
Heron SE
et al.
Genetic variation of CACNA1H in idiopathic generalized epilepsy.
Ann. Neurol.,
2004
Apr
, 55 (595-6).
303
Welsby PJ
et al.
A mechanism for the direct regulation of T-type calcium channels by Ca2+/calmodulin-dependent kinase II.
J. Neurosci.,
2003
Nov
5
, 23 (10116-21).
304
Delisle BP
et al.
Monovalent cations contribute to T-type calcium channel (Cav3.1 and Cav3.2) selectivity.
J. Membr. Biol.,
2003
Jun
1
, 193 (185-94).
305
Kaku T
et al.
The gating and conductance properties of Cav3.2 low-voltage-activated T-type calcium channels.
Jpn. J. Physiol.,
2003
Jun
, 53 (165-72).
306
Perez-Reyes E
Molecular physiology of low-voltage-activated t-type calcium channels.
Physiol. Rev.,
2003
Jan
, 83 (117-61).
307
Ferron L
et al.
Angiotensin II signaling pathways mediate expression of cardiac T-type calcium channels.
Circ. Res.,
2003
Dec
12
, 93 (1241-8).
308
Yunker AM
et al.
Low-voltage-activated ("T-Type") calcium channels in review.
J. Bioenerg. Biomembr.,
2003
Dec
, 35 (533-75).
309
Chen Y
et al.
Association between genetic variation of CACNA1H and childhood absence epilepsy.
Ann. Neurol.,
2003
Aug
, 54 (239-43).
310
Chemin J
et al.
[Functional specificity of T-type calcium channels and their roles in neuronal differentiation]
J. Soc. Biol.,
2003
, 197 (235-47).
311
Mariot P
et al.
Overexpression of an alpha 1H (Cav3.2) T-type calcium channel during neuroendocrine differentiation of human prostate cancer cells.
J. Biol. Chem.,
2002
Mar
29
, 277 (10824-33).
312
Zhang Y
et al.
Mutations in high-voltage-activated calcium channel genes stimulate low-voltage-activated currents in mouse thalamic relay neurons.
J. Neurosci.,
2002
Aug
1
, 22 (6362-71).
313
Wang YQ
et al.
[Functional analysis of the human T-type calcium channel alpha 1H subunit gene in cellular proliferation]
Yi Chuan Xue Bao,
2002
, 29 (659-65).
314
Kushmerick C
et al.
Changes in Ca(2+) channel expression upon differentiation of SN56 cholinergic cells.
Brain Res.,
2001
Oct
19
, 916 (199-210).
315
Perez-Reyes E
et al.
Molecular characterization of two members of the T-type calcium channel family.
Ann. N. Y. Acad. Sci.,
1999
Apr
30
, 868 (131-43).
316
Cribbs LL
et al.
Cloning and characterization of alpha1H from human heart, a member of the T-type Ca2+ channel gene family.
Circ. Res.,
1998
Jul
13
, 83 (103-9).